🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers market the substance there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have cautions that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.

Several experts said the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.

Several content creators try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, risking fines, legal action or imprisonment.

Platform Response and Content Elimination

According to TikTok, the service has taken down problematic content and banned associated keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also found groups with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of weight loss, positive reviews and detailed guides for mixing or injecting at home.

After moments of joining one group, a vendor shared WhatsApp details, where most purchases occur. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Product Information and Pricing

Within these communities, posts display black plastic packages with postal service stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may expose patients to potentially serious medical dangers”.